跳至主要内容
临床试验/NCT04558528
NCT04558528已完成不适用

Clinical Validation of Novel Malaria Diagnostic Tools for Point-of-Care Testing

Foundation for Innovative New Diagnostics, Switzerland2 个研究点 分布在 2 个国家目标入组 640 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
640
试验地点
2
主要终点
Clinical performance assessment

研究概览

简要总结

In this study, a prospective evaluation of novel malaria diagnostic tools under development will be performed in malaria-endemic countries to assess their clinical performance for detection of malaria at point-of-care (POC). This study aims to support product development efforts and aims to provide early stage (TLR~5) technology developers with valuable information on performance and basic feasibility data that can help to accelerate development.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 5 years or older
  • Presenting at the study site with symptoms and signs suggestive of malaria
  • Freely agreeing to participate by signing an informed consent form (adults aged 18 and older and parent/legal guardian of a child) and providing assent (children aged 13-17)
  • Willing to provide sample at enrolment

排除标准

  • Presence of symptoms and signs of severe disease and/or central nervous system infections, as defined by WHO guidelines

结局指标

主要结局

Clinical performance assessment

时间窗: up to 6 months

Point estimates of clinical performance characteristics with 95% confidence intervals (sensitivity, specificity, NPV, PPV, and DOR) of nPOC using nPCR as reference for detecting malaria in patients with symptoms suggestive of malaria

Concordance

时间窗: up to 6 months

Point estimate with 95% confidence intervals of the percentage agreement in interpreting malaria diagnostics between the app and visual reading

次要结局

未报告次要终点

研究者

发起方
Foundation for Innovative New Diagnostics, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验